Summary and Analysis
In April 2022 the White House Office of National Drug Control Policy (ONDCP) published the Biden Administration’s inaugural National Drug Control Strategy. The strategy covers a wide range of issues from harm reduction, such as naloxone, drug test strips, and syringe services programs, to many law enforcement initiatives. It also calls for “actions that will expand access to evidence-based treatments.” On its face, this would appear to be more of a call for increased funding for pharmaceutical treatment drugs and less of a support for multiple pathways to recovery and recovery support services.
The response from some recovery advocacy organizations has been positive. For example, Faces and Voices of Recovery (FAVOR) supports the recommendation for a $1 billion increase to SAMHSA’s Substance Abuse Prevention and Treatment Block Grant, but is advocating that “at least 10% of funds are dedicated to peer-based recovery support services” and “sustainability for peer services in States by expanding the availability of health systems for substance use.”
CLICK HERE to view the National Drug Control Strategy Fact Sheet
Excerpted from Office of National Drug Control Policy (ONDCP)
President Joe Biden sent his Administration’s inaugural National Drug Control Strategy to Congress at a time when drug overdoses have reached a record high. The Strategy delivers on the call to action in President Biden’s Unity Agenda through a whole-of-government approach to beat the overdose epidemic. It proposes targeted actions to expand access to evidence-based prevention, harm reduction, treatment and recovery services while reducing the supply of drugs like fentanyl.
